의료용 체온계 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the medical thermometer market size is expected to grow from USD 2.29 billion in 2025 to USD 2.46 billion in 2026 and is forecast to reach USD 3.55 billion by 2031 at 7.57% CAGR over 2026-2031.

This report is Segmented by Product Type (Mercury-Based, Mercury-Free [Infrared (Contact-Less), Digital (Contact), Smart / Connected]), by Measurement Point (Forehead, Oral/Axillary, and More), by End User (Hospitals, Clinics and Physician Offices, and More), by Patient Age Group (Neonatal, Pediatric, Adult), by Geography (North America, Europe, Asia-Pacific, and More).

Global Medical Thermometer Market Trends and Insights

Explosion of home-use digital & smart thermometry post-COVID

Remote-care reimbursement now spans Medicare, and 81% of clinicians integrate temperature tracking into RPM protocols, lifting consumer demand for connected devices that feed data directly into telehealth dashboards. Smart-thermometer fleets exceeding 3 million units provide anonymized datasets used to forecast regional fever spikes, illustrating how the medical thermometer market increasingly overlaps with public-health analytics. Household adoption remains highest in North America, yet Asia-Pacific growth accelerates as mobile-health ecosystems mature and price points fall to mass-market levels. Data-driven platforms encourage repeat sales because firmware and algorithm upgrades extend device lifecycles. Device makers now bundle temperature probes with pulse-ox and blood-pressure modules, creating multi-parameter kits that anchor patient engagement.

Hospital infection-control protocols favoring contact-less devices

Clinical workflows prioritize non-contact thermometry to cut disinfection-time and cross-infection risks. National guidelines in Canada and Australia highlight infrared or single-use solutions in triage and aged-care settings. Procurement teams embed non-contact requirements in tenders, pushing vendors to refine sensor accuracy through emissivity-compensation algorithms. Although peer-reviewed studies still flag sub-0.8 correlation with core temperature, suppliers counter by integrating dual-sensor arrays and calibration certificates for each batch. Growth is further supported by thermal-screening gates deployed in airports and large venues that were repurposed for routine hospital entry points.

Accuracy & calibration variability across low-cost imports

Intra-class correlation coefficients below 0.8 for many budget infrared units undermine clinician trust and can delay febrile-illness diagnosis. Larger providers now demand NIST-traceable calibration reports, increasing compliance costs for suppliers without in-house metrology labs. The FDA's forthcoming Quality Management System Regulation, aligned with ISO 13485:2016, may exclude non-certified importers, reshaping the competitive field.

Other drivers and restraints analyzed in the detailed report include:

1. Growing pediatric & geriatric populations needing frequent monitoring
2. Integrated vital-sign platforms bundling temperature sensors
3. Rising cybersecurity concerns around connected thermometers

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Mercury-free thermometers represented USD 1.65 billion of the 2025 medical thermometer market size and continue to expand at 8.29% CAGR, buoyed by sweeping prohibitions on mercury under EU Regulation 2017/852. Digital stick thermometers dominate volume sales because caregivers value their sub-20-second readouts and absence of hazardous materials. Infrared guns and advanced ear probes reinforce infection-control strategies in crowded triage zones. Smart mercury-free units that sync with mobile apps are the fastest-growing niche, aided by cloud dashboards that convert raw temperature into longitudinal health trends.

Since transportation rules classify mercury devices as hazardous goods, distributors increasingly purge legacy stock in favor of mercury-free portfolios. Early movers such as Microlife leveraged R&D scale to certify products under the EU Medical Device Regulation, gaining a price premium over generic brands. Semiconductor shortages challenge smaller players lacking long-term supplier contracts, yet vertically integrated giants secure priority allocations, protecting output during demand spikes. As environmental-health frameworks tighten in Latin America and parts of Africa, the medical thermometer market faces virtually irreversible migration toward mercury-free solutions.

Oral/axillary modalities delivered USD 1.44 billion revenue in 2025, or 62.90% of the medical thermometer market, reflecting routine ward protocols and reimbursement familiarity. However, forehead scanners notch an 8.06% CAGR because they minimize surface-contact and accelerate triage. Recent sensor-fusion algorithms adjust for emissivity and ambient drift, pulling root-mean-square error below 0.2 °C in controlled studies, narrowing the gap with oral probes.

Regulators in Australia and Canada now list non-contact screening as preferred practice in aged-care infection-control manuals. Clinical buyers appreciate the ability to read dozens of patients per minute without probe covers, cutting consumable expense. Meanwhile, tympanic devices retain relevance in pediatrics thanks to minimal discomfort and stable ear-canal core-temperature correlation. Innovations such as thermochromic masks that change color above 37.5 °C illustrate how forehead-centric solutions extend beyond handheld form factors. Manufacturers that reconcile speed, hygiene and accuracy are best placed to win tenders in the evolving medical thermometer market.

Complete Report Scope:

• By Product Type
  • Mercury-Based
  • Mercury-Free
    • Infrared (Contact-less)
    • Digital (Contact)
    • Smart / Connected
• By Measurement Point
  • Forehead
  • Ear (Tympanic)
  • Oral/Axillary
  • Rectal
• By End User
  • Hospitals
  • Clinics and Physician Offices
  • Home-care Settings
  • Others
• By Patient Age Group
  • Neonatal
  • Pediatric
  • Adult
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America delivered USD 838 million of the 2025 medical thermometer market, holding 36.60% share on the back of robust RPM reimbursement, hospital digitization and regulatory clarity. The region's providers increasingly mandate cybersecurity certifications, creating barriers for low-cost importers but supporting premium ASPs. Growth remains healthy at 6.58% CAGR as home-based chronic-care programs scale nationwide.

Asia-Pacific, valued at USD 654 million in 2025, records the fastest 9.11% CAGR to 2031, underpinned by China's hospital-digitization subsidies and India's Ayushman Bharat insurance rollout. Although medtech investment fell from 2021 peaks, consolidation allows established thermometer makers to buy distressed sensor firms and capture local distribution networks. Japan's rapidly aging population favors continuous monitoring wearables, while Southeast Asian clinics leapfrog straight to mobile-linked devices due to smartphone ubiquity.

Europe holds a steady 23.80% revenue slice as the Medical Device Regulation tightens post-market surveillance, prompting smaller brands to exit rather than re-certify. Mercury prohibitions remain a decisive tailwind and keep the medical thermometer market aligned with sustainability mandates. Middle East and Africa show double-digit expansion from a low base, propelled by infection-surveillance grants and private-hospital projects, yet logistical hurdles and currency volatility temper near-term uptake. Latin America's public-sector tenders favor budget models, but private insurers increasingly reimburse connected devices, gradually shifting the mix toward higher-value smart thermometers.

1. A&D Company Ltd
2. American Diagnostic Corp
3. Actherm Medical Corp
4. Exergen Corp
5. Citizen Systems Japan Co Ltd
6. Microlife Corp
7. OMRON
8. Cardinal Health
9. Innovo Medical
10. Welch Allyn Inc (Baxter International Inc.)
11. Tecnimed Srl
12. Terumo
13. VivaLnk Inc
14. iProven
15. Kinsa Inc
16. HuBDIC Co Ltd
17. Hartmann Group
18. BPL

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Explosion of home-use digital & smart thermometry post-COVID
  • 4.2.2 Hospital infection-control protocols favouring contact-less devices
  • 4.2.3 Growing paediatric & geriatric populations needing frequent monitoring
  • 4.2.4 Integrated vital-sign platforms bundling temperature sensors
  • 4.2.5 AI-powered fever-prediction algorithms embedded in wearables (under-reported)
  • 4.2.6 Climate-change induced vector-borne disease surveillance programmes (under-reported)
• 4.3 Market Restraints
  • 4.3.1 Regulatory moves to ban mercury thermometers in emerging markets
  • 4.3.2 Accuracy & calibration variability across low-cost imports
  • 4.3.3 Rising cybersecurity concerns around connected thermometers (under-reported)
  • 4.3.4 Sensor-grade semiconductor shortages disrupting supply (under-reported)
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value)

• 5.1 By Product Type
  • 5.1.1 Mercury-Based
  • 5.1.2 Mercury-Free
    • 5.1.2.1 Infrared (Contact-less)
    • 5.1.2.2 Digital (Contact)
    • 5.1.2.3 Smart / Connected
• 5.2 By Measurement Point
  • 5.2.1 Forehead
  • 5.2.2 Ear (Tympanic)
  • 5.2.3 Oral/Axillary
  • 5.2.4 Rectal
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Clinics and Physician Offices
  • 5.3.3 Home-care Settings
  • 5.3.4 Others
• 5.4 By Patient Age Group
  • 5.4.1 Neonatal
  • 5.4.2 Pediatric
  • 5.4.3 Adult
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
  • 6.3.1 A&D Company Ltd
  • 6.3.2 American Diagnostic Corp
  • 6.3.3 Actherm Medical Corp
  • 6.3.4 Exergen Corp
  • 6.3.5 Citizen Systems Japan Co Ltd
  • 6.3.6 Microlife Corp
  • 6.3.7 Omron Healthcare Inc
  • 6.3.8 Cardinal Health
  • 6.3.9 Innovo Medical
  • 6.3.10 Welch Allyn Inc (Baxter International Inc.)
  • 6.3.11 Tecnimed Srl
  • 6.3.12 Terumo Corp
  • 6.3.13 VivaLnk Inc
  • 6.3.14 iProven
  • 6.3.15 Kinsa Inc
  • 6.3.16 HuBDIC Co Ltd
  • 6.3.17 Paul Hartmann AG
  • 6.3.18 BPL Medical Technologies

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment